Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by ToothlessGrinon Feb 25, 2021 3:38pm
112 Views
Post# 32660648

RE:RE:New Blood

RE:RE:New BloodI can imagine its been a tough slog for the long timers. I've lived it with RVX... believe me. For what its worth the broker i spoke has never heard of RVX!!! So thats not real awesome for me but I as i consume the science here, the deal partners, the who, the how, the what, and the why, im hoping my timing was right for once!!
TG
<< Previous
Bullboard Posts
Next >>